David A. Siegel Black Diamond Therapeutics, Inc. Transaction History

Two Sigma Advisers, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.67 - $5.74 $17,622 - $37,884	-6,600 Reduced 6.41%	96,300 $488,000
Q4 2023 Feb 14, 2024	BUY	$1.77 - $3.03 $132,219 - $226,340	74,700 Added 264.89%	102,900 $289,000
Q3 2023 Nov 14, 2023	BUY	$2.87 - $4.99 $44,198 - $76,846	15,400 Added 120.31%	28,200 $80,000
Q2 2023 Aug 14, 2023	SELL	$1.43 - $6.18 $233,233 - $1.01 Million	-163,100 Reduced 92.72%	12,800 $64,000
Q1 2023 May 15, 2023	SELL	$1.35 - $3.14 $49,410 - $114,924	-36,600 Reduced 17.22%	175,900 $332,000
Q4 2022 Feb 14, 2023	SELL	$1.27 - $2.51 $2,667 - $5,271	-2,100 Reduced 0.98%	212,500 $382,000
Q3 2022 Nov 14, 2022	SELL	$1.68 - $4.01 $89,880 - $214,535	-53,500 Reduced 19.96%	214,600 $363,000
Q2 2022 Aug 15, 2022	SELL	$1.5 - $3.63 $41,250 - $99,825	-27,500 Reduced 9.3%	268,100 $660,000
Q1 2022 May 16, 2022	BUY	$2.66 - $5.61 $258,286 - $544,731	97,100 Added 48.92%	295,600 $819,000
Q4 2021 Feb 14, 2022	BUY	$5.18 - $8.48 $89,096 - $145,856	17,200 Added 9.49%	198,500 $1.06 Million
Q3 2021 Nov 15, 2021	BUY	$8.46 - $12.42 $821,466 - $1.21 Million	97,100 Added 115.32%	181,300 $1.53 Million
Q2 2021 Aug 16, 2021	BUY	$12.19 - $28.17 $504,666 - $1.17 Million	41,400 Added 96.73%	84,200 $1.03 Million
Q1 2021 May 17, 2021	BUY	$22.23 - $34.75 $244,530 - $382,250	11,000 Added 34.59%	42,800 $1.04 Million
Q4 2020 Feb 16, 2021	BUY	$29.47 - $35.0 $937,146 - $1.11 Million	31,800 New	31,800 $1.02 Million

100

47.3M

108K

24.8K

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $158M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.